• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 99 pages
Exam (elaborations)

Board Certified Psychiatric Pharmacist (BCPP) Exam 2026: Professional Certification Practice Test — Psychopharmacology, Mental Health Disorders, Medication Management & Patient Care — 190 Multiple-Choice Questions with Answers & Detailed Rationales

Document preview thumbnail
Preview 4 out of 99 pages

Board Certified Psychiatric Pharmacist (BCPP) Exam 2026: Professional Certification Practice Test — Psychopharmacology, Mental Health Disorders, Medication Management & Patient Care — 190 Multiple-Choice Questions with Answers & Detailed Rationales

Content preview

Board Certified Psychiatric Pharmacist (BCPP) Exam 2026:
Professional Certification Practice Test — Psychopharmacology,
Mental Health Disorders, Medication Management & Patient Care —
190 Multiple-Choice Questions with Answers & Detailed Rationales




Section 1: Mood Disorders — Depressive Disorders

Question 1



A 34-year-old woman with major depressive disorder has failed adequate trials of sertraline
and escitalopram. She has no psychotic features and no history of mania or hypomania.
Which agent is most appropriate to augment her current antidepressant?



A. Lithium

B. Lamotrigine

C. Aripiprazole

D. Buspirone



Correct Answer: C



Explanation: Aripiprazole is FDA-approved as adjunctive therapy for MDD and has robust
evidence for augmentation. Lithium has weaker evidence for MDD augmentation.



Question 2



A patient with major depressive disorder and concurrent seizure disorder requires an
antidepressant that will not lower his seizure threshold. Which agent is most appropriate?



A. Bupropion

,B. Clomipramine

C. Sertraline

D. Amoxapine



Correct Answer: C



Explanation: SSRIs like sertraline are generally safe in epilepsy and may raise seizure
threshold. Bupropion and tricyclics lower seizure threshold.



Question 3



A 28-year-old woman with MDD is currently taking an oral contraceptive and reports new-
onset breakthrough bleeding after starting an antidepressant. Which antidepressant is most
likely responsible?



A. Sertraline

B. Fluoxetine

C. Venlafaxine

D. Bupropion



Correct Answer: D



Explanation: Bupropion induces CYP3A4, accelerating oral contraceptive metabolism and
reducing efficacy. SSRIs and SNRIs generally do not significantly affect OC efficacy.



Question 4



A patient with treatment-resistant depression has failed SSRIs, SNRIs, and augmentation
with atypical antipsychotics. Which agent, when added to an MAOI, requires a washout
period due to risk of serotonin syndrome?

,A. Lithium

B. Mirtazapine

C. Sertraline

D. Bupropion



Correct Answer: C



Explanation: SSRIs and MAOIs both increase serotonergic activity; combination causes
potentially fatal serotonin syndrome. Requires 2-week washout.



Question 5



A 45-year-old man with MDD and chronic neuropathic pain is being initiated on duloxetine.
What baseline monitoring is most important?



A. Serum sodium

B. Blood pressure

C. Liver function tests

D. Complete blood count



Correct Answer: B



Explanation: SNRIs like duloxetine cause dose-dependent blood pressure elevation. Baseline
and periodic BP monitoring is essential.



Question 6

, A pregnant patient in her third trimester has severe MDD and is considering antidepressant
continuation. Which neonatal complication is most associated with late-trimester SSRI
exposure?



A. Neural tube defects

B. Persistent pulmonary hypertension

C. Ebstein anomaly

D. Limb malformations



Correct Answer: B



Explanation: Late-trimester SSRI exposure is associated with persistent pulmonary
hypertension of the newborn (PPHN). Neural tube defects are linked to first-trimester
exposure.



Question 7



A 62-year-old man with MDD and BPH is concerned about urinary retention. Which
antidepressant is most appropriate to avoid?



A. Duloxetine

B. Sertraline

C. Amitriptyline

D. Bupropion



Correct Answer: C



Explanation: Tricyclic antidepressants like amitriptyline have strong anticholinergic effects
that worsen urinary retention. SNRIs and SSRIs have minimal anticholinergic activity.

Document information

Uploaded on
October 15, 2026
Number of pages
99
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$23.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
305
Last sold
-



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions